← Back to Search

Other

Amount of Celastrol Administered for Safety Concerns

N/A
Recruiting
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights

Study Summary

Five healthy participants with normal sperm counts and motility will ingest increasing doses of celastrol over a period of several days. After each dose ingestion the participants will provide an ejaculate the next day for sperm analysis. The objective is to see if increasing ingestion levels of celastrol will affect the sperm counts and motility of the participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amount of Sperm in 1 mL of Ejaculate after Celastrol Ingestion
Motility of Sperm in 1 mL of Ejaculate after Celastrol Ingestion

Trial Design

1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Increasing doses of Celastrol to each of five male subjects

Find a Location

Who is running the clinical trial?

Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
35 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorLegend Labz, Inc.
1 Previous Clinical Trials
35 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025